Pharmafile Logo

What oncologists really want from booth strategy

August 19, 2025 | Congress, Inizio, oncology 

- PMLiVE

Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company 

At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30 clients and delivering 185 projects, Inizio witnessed the shift toward smarter, more sustainable congress environments.

Key takeaways included:

  • Oncologists want interactive learning: Engagement is moving beyond slides, with responsive booths, interactive LED walls, and digital-first experiences extending conversations well past the industry’s six-minute average.

  • Smart spaces are here to stay: With heat mapping, AI-powered personalization, and real-time content optimization, booths are evolving into dynamic, intelligent environments that adapt to audience needs.

  • Sustainability as strategy: Inizio’s circularity-first booth design delivered a 70% CO₂e reduction, 70.7% recyclability, and major cost savings – results that earned industry-leading awards and set a benchmark for measurable impact.

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are becoming essential to cut through the noise. The future of congress engagement will be intentional, data-informed, and deeply aligned with healthcare professionals’ learning preferences.

Read Simon’s full article here, or explore more in Inizio’s on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

A safe place to talk about Crohn’s

Published in eyeforpharma April 2017 by Mariel Metcalfe

Patient Assistance Programme Evaluation for Cardiovascular Conditions

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

20 questions: Round 1

As it's our 20th year anniversary, we invited our employees to play 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/

Brand tracking research

A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline...

Pharma China Annual Forum 2017

We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

Healthcare Market Research in the Gulf: 3 lessons I’ve learned

A few key considerations for conducting healthcare market research in the Gulf

Case study: Multiple Sclerosis new medical device research

Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

Patient Centricity: Turning Rhetoric into Reality

Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates